GPX4 and cancer: Data showed that loss of GPX4 function either by genetic inactivation or pharmacological treatment could induce selective ferroptosis in cancer cells in vitro and also guard against tumor recrudesce in mice [84, 85], indicating that rationally manipulating ferroptosis or necroptosis or both may be an attractive way to treat certain kinds of cancers in clinic.